Learn more

By Elliot Gulliver-Needham Genetics specialist Benchmark Holdings has suffered a 17 per cent dip in group revenue over the last nine months, as the company attempts to escape from the London Stock Exchange by getting bought out. The company reported “solid performance in genetics and advanced nutrition amidst continuing soft shrimp markets” in its quarterly results, but revenue at its health business plummeted 43 per cent. Overall, it reported an operating loss of £10.2m over the last nine months, compared to only £3m lost in the same period last year. In January, Benchmark Holdings announced …

cuu